NCT05439863View on ClinicalTrials.gov

TAVR for Aortic Valve Disease

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 30, 2032

Study Completion Date

December 30, 2037

Conditions
Aortic Valve Disease
Interventions
DEVICE

transcatheter heart valve

patients with severe aortic valve disease underwent transcatheter heart valve

Trial Locations (1)

210006

RECRUITING

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER